ARCHIVE

• DIAGNOSTIC NEWS IN BRIEF
  March 11, 2002

• OTS NEWS IN BRIEF
  March 11, 2002

• NHI Price Revision in April Will Hit Drug Companies Hard: Mr Fujiyama of FPMAJ
  March 11, 2002

• Kuraya Sanseido Aims at Consolidated Sales of \1,330 Bil. in FY2004
  March 11, 2002

• GE Information Supply Fee to Be Introduced: Revision -3-
  March 4, 2002

• NanoCarrier Ties Up with Amarin to Develop New DDS Technology
  March 4, 2002

• GE Information Supply Fee to Be Introduced: Revision -2-
  March 4, 2002

• New 3-Drug Therapy Using Omeprazole to Be Approved for Hp Eradication
  March 4, 2002

• Advaferon and Rebetol + Intron A Effective for Refractory Hepatitis C
  March 4, 2002

• Number of Drugs Approved in 2001 Totals About 2,400
  March 4, 2002

• Japan, Singapore to Cooperate in the Field of Biomaterials
  March 4, 2002

• Precautions for 4 Drugs Including Acarbose Revised
  March 4, 2002

• Novo Nordisk Offers Grant for Research on Low Stature
  March 4, 2002

• Administration Restrictions on IFN Lifted
  March 4, 2002

• Abolition of Long-term Admission Fees from Insurance Coverage Hits Hospitals:Dr Itouji of JMA
  March 4, 2002

• Korosho Calls on Medical Professionals to Cooperate in Immediate PMS
  March 4, 2002

• Bungyo Rate Increases to 44.9% in October 2001
  March 4, 2002

• REGULATORY NEWS IN BRIEF
  March 4, 2002

• AJHA Holds 1st Seminar on TQM
  March 4, 2002

• BULLETIN
  March 4, 2002

ページ

• « 先頭
• ‹ Prev
• …
• 695
• 696
• 697
• 698
• 699
• 700
• 701
• 702
• 703
• …
• Next ›
• 最終 »